142 related articles for article (PubMed ID: 7039814)
1. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275).
Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
Cancer; 1982 Apr; 49(8):1555-60. PubMed ID: 7039814
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu).
Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
Am J Clin Oncol; 1983 Apr; 6(2):175-80. PubMed ID: 6829492
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of large bowel carcinoma--fluorouracil (FU) + hydroxyurea (HU) vs. methyl-CCNU, oncovin, fluorouracil, and streptozotocin (MOF-Strep). An Eastern Cooperative Oncology Group study.
Engstrom PF; MacIntyre JM; Schutt AJ; Douglass HO
Am J Clin Oncol; 1985 Oct; 8(5):358-61. PubMed ID: 2932908
[TBL] [Abstract][Full Text] [Related]
6. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
Kemeny N; Yagoda A; Braun D
Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
[TBL] [Abstract][Full Text] [Related]
7. A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma.
Kemeny N; Yagoda A; Braun D; Golbey R
Cancer; 1979 Jan; 43(1):78-82. PubMed ID: 367575
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine.
Joss RA; Goldberg RS; Yates JW
Med Pediatr Oncol; 1979; 7(3):251-5. PubMed ID: 542190
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
13. Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-Strep).
Kemeny N; Yagoda A; Braun D; Golbey R
Cancer; 1980 Mar; 45(5):876-81. PubMed ID: 7260839
[TBL] [Abstract][Full Text] [Related]
14. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea.
Stroehlein JR; Bedikian AY; Karlin DA; Valdivieso M; Bennetts RW; Bodey GP
Am J Clin Oncol; 1982 Aug; 5(4):421-7. PubMed ID: 7113964
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of large intestinal carcinoma. Current results and future prospects.
Schein PS; Kisner D; MacDonald JS
Cancer; 1975 Dec; 36(6 Suppl):2418-20. PubMed ID: 764960
[TBL] [Abstract][Full Text] [Related]
16. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA
J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexate.
Craig JB; Jackson DV; Richards FR; Muss HB; White DR; Cooper MR; Stuart JJ; Spurr CL
Am J Clin Oncol; 1987 Feb; 10(1):44-6. PubMed ID: 3825991
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two combination chemotherapy regimens in advanced colorectal cancer.
Epenetos AA; Amos C; Collis C; Slevin M; Rohatiner A; Baille-Johnson H; Pitts J; Wrigley PF
Br Med J; 1980 Aug; 281(6240):587-8. PubMed ID: 7427380
[No Abstract] [Full Text] [Related]
19. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
[TBL] [Abstract][Full Text] [Related]
20. Oral uracil/ftorafur (UFT) plus leucovorin as first-line chemotherapy and salvage therapy with weekly high-dose 5-fluorouracil/leucovorin for the treatment of metastatic colorectal cancer.
Yang TS; Wang JY; Tang R; Hsu KC; Chen JS
Jpn J Clin Oncol; 2002 Sep; 32(9):352-7. PubMed ID: 12417601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
